Furthermore, we corroborated the in vitro efficacy of AZD6738/olaparib observed in ATM-KO FaDu cells using ATM-deficient lung carcinoma cell lines, and in vivo xenograft and PDX ATM-deficient models. Here, ATM is linked to lung carcinoma.